Meta-analysis demonstrates association of the TGF-β1 gene -C509T polymorphism with susceptibility to IgA nephropathy in European but not in Asian populations

Genetics and Molecular Research

Volumn 12, Issue 1, 2013, Pages 434-442

  Wang, H ^a,b   Li, P ^b   Feng, Z C ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

C509T polymorphism; IgA nephropathy; Meta analysis; TGF 1 gene

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; ASIAN; CASE CONTROL STUDY; ETHNIC DIFFERENCE; EUROPEAN AMERICAN; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HIGH RISK POPULATION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MOLECULAR PATHOLOGY; RISK FACTOR; TRANSFORMING GROWTH FACTOR BETA1 GENE; CAUCASIAN; COHORT ANALYSIS; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; META ANALYSIS;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLOMERULONEPHRITIS, IGA; HUMANS; POLYMORPHISM, GENETIC; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84887382032     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2013.February.8.8     Document Type: Article

References (34)

1. Awad MR, El-Gamel A, Hasleton P, Turner DM, et al. (1998). Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 66: 1014-1020.
2. Baan CC, Balk AH, Holweg CT, van Riemsdijk IC, et al. (2000). Renal failure after clinical heart transplantation is associated with the TGF-beta 1 codon 10 gene polymorphism. J. Heart Lung Transplant. 19: 866-872.
3. Bantis C, Heering PJ, Aker S, Klein-Vehne N, et al. (2004). Association of interleukin-10 gene G-1082A polymorphism with the progression of primary glomerulonephritis. Kidney Int. 66: 288-294.
4. Bhowmik D, Sinha S, Gupt A, Tiwari SC, et al. (2011). Clinical approach to rapidly progressive renal failure. J. Assoc. Physicians India 59: 38-41.
5. Brezzi B, Del Prete D, Lupo A, Magistroni R, et al. (2009). Primary IgA nephropathy is more severe in TGF-beta1 high secretor patients. J. Nephrol. 22: 747-759.
6. Carturan S, Roccatello D, Menegatti E, Di Simone D, et al. (2004). Association between transforming growth factor beta1 gene polymorphisms and IgA nephropathy. J. Nephrol. 17: 786-793.
7. Chen BP, Wei YS, Xie JS and Huang HL (2005). Transforming growth factor beta1 gene polymorphisms in ZHUANG and HAN nationality in Guangxi Province. Chin. J. Anat. 28: 379-380.
8. Cotton SA, Gbadegesin RA, Williams S, Brenchley PE, et al. (2002). Role of TGF-beta1 in renal parenchymal scarring following childhood urinary tract infection. Kidney Int. 61: 61-67.
9. Egger M, Davey SG, Schneider M and Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
10. Grainger DJ, Heathcote K, Chiano M, Snieder H, et al. (1999). Genetic control of the circulating concentration of transforming growth factor type beta1. Hum. Mol. Genet. 8: 93-97.
11. Higgins JP and Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat. Med. 21: 1539-1558.
12. Hohenstein B, Daniel C, Wittmann S and Hugo C (2008). PDE-5 inhibition impedes TSP-1 expression, TGF-beta activation and matrix accumulation in experimental glomerulonephritis. Nephrol. Dial. Transplant. 23: 3427-3436.
13. Holla LI, Fassmann A, Benes P, Halabala T, et al. (2002). 5 polymorphisms in the transforming growth factor-β 1 gene (TGF-beta1) in adult periodontitis. J. Clin. Periodontol. 29: 336-341.
14. Iwano M (2010). EMT and TGF-beta in renal fibrosis. Front Biosci. 2: 229-238.
15. Julian BA, Wyatt RJ, Matousovic K, Moldoveanu Z, et al. (2007). IgA nephropathy: a clinical overview. Contrib. Nephrol. 157: 19-26.
16. Kovacs TJ, Harris S, Vas TK, Seres I, et al. (2006). Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy. J. Nephrol. 19: 732-738.
17. Lacha J, Hubacek JA, Potmesil P, Viklicky O, et al. (2001). TGF-beta I gene polymorphism in heart transplant recipients-effect on renal function. Ann. Transplant. 6: 39-43.
18. Lee HS (2011). Pathogenic role of TGF-beta in the progression of podocyte diseases. Histol. Histopathol. 26: 107-116.
19. Li SL, Lin X, Wang J, Yang F, et al. (2011). Relationship of transforming growth factorβ1 gene-509C/T polymorphism with IgA nephropathy in Western Guangxi. China J. Modern Med. 21: 1607-1610.
20. Lim CS, Kim YS, Chae DW, Ahn C, et al. (2005). Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with susceptibility to and progression of IgA nephropathy. Clin. Nephrol. 63: 61-67.
21. Narita I, Saito N, Goto S, Jin S, et al. (2002). Role of uteroglobin G38A polymorphism in the progression of IgA nephropathy in Japanese patients. Kidney Int. 61: 1853-1858.
22. Narita I, Goto S, Saito N, Song J, et al. (2003). Genetic polymorphism of NPHS1 modifies the clinical manifestations of Ig A nephropathy. Lab. Invest. 83: 1193-1200.
23. Petitti DB (1994). Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis. Oxford University Press, New York.
24. Qin W, Zhang YJ, Tan CY, Liu XR, et al. (2008). Association of TGF-β1 gene polymorphism with IgA nephropathy. West China Med. J. 23: 61-63.
25. Sato F, Narita I, Goto S, Kondo D, et al. (2004). Transforming growth factor-beta1 gene polymorphism modifies the histological and clinical manifestations in Japanese patients with IgA nephropathy. Tissue Antigens 64: 35-42.
26. Song JH, Lee SW, Suh JH, Kim ES, et al. (2003). The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy. Clin. Nephrol. 60: 318-326.
27. Syrjanen J, Hurme M, Lehtimaki T, Mustonen J, et al. (2002). Polymorphism of the cytokine genes and IgA nephropathy. Kidney Int. 61: 1079-1085.
28. Vuong MT, Lundberg S, Gunnarsson I, Wramner L, et al. (2009). Genetic variation in the transforming growth factor-β1 gene is associated with susceptibility to IgA nephropathy. Nephrol. Dial. Transplant. 24: 3061-3067.
29. Wiwanitkit V (2006). Angiotensin-converting enzyme gene polymorphism is correlated to the progression of disease in patients with IgA nephropathy: a meta-analysis. Ren. Fail. 28: 697-699.
30. Xue C, Li YJ, Li CX, Du Y, et al. (2005). Relationship of TGF-β1-509C/T polymorphism with IgA nephropathy in HAN Nationality of Chinese Population. J. Sun Yat-Sen Univ. 26: 260-263.
31. Yamada Y, Miyauchi A, Goto J, Takagi Y, et al. (1998). Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J. Bone Miner. Res. 13: 1569-1576.
32. Yamada Y, Miyauchi A, Takagi Y, Tanaka M, et al. (2001). Association of the C-509→T polymorphism, alone of in combination with the T869→C polymorphism, of the transforming growth factor-beta1 gene with bone mineral density and genetic susceptibility to osteoporosis in Japanese women. J. Mol. Med. 79: 149-156.
33. Yamamoto R, Nagasawa Y, Shoji T, Katakami N, et al. (2012). A candidate gene approach to genetic contributors to the development of IgA nephropathy. Nephrol. Dial. Transplant. 27: 1020-1030.
34. Yokota M, Ichihara S, Lin TL, Nakashima N, et al. (2000). Association of a T29→C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 101: 2783-2787.